General Information
Version
8.1
Revision date
2026-09-13
Product name
Beta-Lactamase Activity Assay Kit
Emergency telephone
+81 (0)3 4520 9637
Icons in SDS
Company Information
company name
Merck Ltd.
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H319, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction.
Precautionary statements
P261 Avoid breathing mist or vapours. P264 Wash skin thoroughly after handling. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves/ eye protection/ face protection. P261 Avoid breathing mist or vapours. P272 Contaminated work clothing should not be allowed out of the workplace. P302 + P352 IF ON SKIN: Wash with plenty of water.
Response
P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Hazardous Ingredients
Nitrocefin Beta-Lactamase Standard Reduced Labelling (<= 125 ml)
Supplemental label elements
none
2.3 Other hazards
None known.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Eye irritation, Category 2 H319: Causes serious eye irritation. Respiratory sensitisation, Category H334: May cause allergy or asthma 1 symptoms or breathing difficulties if inhaled. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction.
